197
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Impact of microparticle formulation approaches on drug burst release: a level A IVIVC

, , , &
Pages 674-684 | Received 05 Oct 2013, Accepted 31 Mar 2014, Published online: 25 Jun 2014

References

  • AHFS DI. 2010. American Hospital Formulary Service. Drug Information from the American Society of Health-System Pharmacists (ASHP). Bethesda, Maryland. Available at: http://www.ahfsdruginformation.com
  • Berchane NS, Carson KH, Rice-Ficht AC, Andrews MJ. Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory. Int J Pharm, 2007;337(1–2):118–26
  • Berchane NS, Jebrail FF, Andrews MJ. Optimization of PLG microspheres for tailored drug release. Int J Pharm, 2010;383(1–2):81–8
  • Bodmeier R. 1997. Verfahren zur in-situ Herstellung von Partikeln. Offenlegungsschrift D.E. patent 197,24,784
  • Bolden-Watson C, Watson MA, Murray KD, Isackson PJ, Richelson E. Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra. J Neurochem, 1993;61(3):1141–3
  • Bouissou C, Rouse J, Price R, van der Walle C. The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release. Pharm Res, 2006;23(6):1295–305
  • Bourne D. 2002. Pharmacokinetics. In: Banker G, Rhodes C, eds. Modern pharmaceutics. New York: Marcel Dekker Inc, pp. 67–92
  • Brodbeck KJ, Gaynor-Duarte AT, Shen TT. 2000. Gel compositions and methods. U.S. Patent 6,130,200
  • Budhian A, Siegel SJ, Winey KI. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol. J Microencapsul, 2005;22(7):773–85
  • Chu D, Fu X, Liu W, Liu K, Li Y. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm, 2006;325(1–2):116–23
  • Chung TW, Tsai YL, Hsieh JH, Tsai WJ. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J Microencapsul, 2006;23(1):15–27
  • Colombo P, Santi P, Bettini R, Brazel CS, Peppas NA. 2000. Drug release from swelling-controlled systems. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker, Inc., pp. 183–210
  • Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sciences, 2001;13:123–33
  • D'Souza S, DeLuca P. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res, 2006;23:460–74
  • El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm, 2010;397(1–2):164–72
  • FDA. 1997. Guidance for industry: Extended release oral dosage forms: 1282 development, evaluation, and application of in vitro/in vivo correlations. Silver Spring, MD: U.S. Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER). Available at: http://www.fda.gov
  • Fernández-Carballido A, Herrero-Vanrell R, Molina-Martínez IT, Pastoriza P. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration: Effect of Labrafil addition on release in vitro. Int J Pharm, 2004;279(1–2):33–41
  • Fernández-Carballido A, Herrero-Vanrell R, Molina-Martínez IT, Pastoriza P. Radiosterilization of indomethacin PLGA/PEG-derivative microspheres: Protective effects of low temperature during gamma-irradiation. Int J Pharm, 2006;313(1–2):129–35
  • Fu K, Harrell R, Zinski K, Um C, Jaklenec A, Frazier J, Lotan N, Burke P, Klibanov AM, Langer R. A potential approach for decreasing the burst effect of protein from PLGA microspheres. J Pharm Sci, 2003;92(8):1582–91
  • Hadjiioannou T, Christian G, Koupparis M, Macheras P. 1993. Quantitative calculations in pharmaceutical practice and research. New York: VCH Publishers Inc., pp. 345–8
  • Herrero-Vanrell R, Ramírez L, Fernández-Carballido A, Refojo MF. Biodegradable PLGA microspheres loaded with Ganciclovir for intraocular administration. Encapsulation technique, in-vitro releases profiles, and sterilization process. Pharm Res, 2000;17:1323–8
  • Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 1963;52:1145–9
  • Holayel SM. 1996. Pharmaceutical studies on parenteral reconstituted suspensions. Egypt, Master degree in Pharmaceutical Sciences: Cairo
  • Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release, 2001;73:121–36
  • Jiang G, Qiu W, DeLuca PP. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Pharm Res, 2003;20:452–9
  • Kamel A, Awad G, Geneidi A, Mortada N. Preparation of intravenous stealthy acyclovir nanoparticles with increased mean residence time. AAPS PharmSciTech, 2009;10(4):1427–36
  • Kanig JL, Goodman H. Evaluative procedures for film-forming materials used in pharmaceutical applications. J Pharm Sci, 1962;51:77–83
  • Kishida A, Murakami K, Goto H, Akashi M, Kubita H, Endo T. Polymer drugs and polymeric drugs X: Slow release of 5-fluorouracil from biodegradable poly(g-glutamic acid) and its benzyl ester matrices. J Bioact Compat Polym, 1998;13:270–8
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 1983;15:25–35
  • Kranz H, Yilmaz E, Brazeau GA, Bodmeier R. In vitro and in vivo drug release from a novel in situ forming drug delivery system. Pharm Res, 2008;25(6):1347–54
  • Krugner-Higby L, KuKanich B, Schmidt B, Heath TD, Brown C, Smith LJ. Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in Rhesus Macaques. J Pharmacol Exp Ther, 2009;33(1):135–41
  • Lambert WJ, Peck KD. Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins. J Control Release, 1995;33(1):189–95
  • Li J, Chen F, Hu C, He L, Yan K, Zhou L, Pan W. Optimized preparation of in situ forming microparticles for the parenteral delivery of vinpocetine. Chem Pharm Bull, 2008;56(6):796–801
  • Luan X, Bodmeier R. In situ forming microparticle system for controlled delivery of leuprolide acetate: Influence of the formulation and processing parameters. Eur J Pharm Sciences, 2006a;27:143–9
  • Luan X, Bodmeier R. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems. J Control Release, 2006b;110:266–72
  • Machida Y, Onishi H, Kurita A, Hata H, Morikawa A, Machida Y. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. J Control Rel, 2000;66(17):159–75
  • Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Rel, 2005;107(2):215–28
  • Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm, 2007;334(1–2):137–48
  • Martínez-Sancho C, Herrero-Vanrell R, Negro S. Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: Influence of fatty and non-fatty additives. J Microencapsul, 2003;20:799–810
  • Martínez-Sancho C, Herrero-Vanrell R, Negro S. Study of gamma-irradiation effects on aciclovir poly(lactic-co-glycolic) acid microspheres for intravitreal administration. J Control Release, 2004;99(1):41–52
  • Monedero FM, Fabra MJ, Talens P, Chiralt A. Effect of oleic acid–beeswax mixtures on mechanical, optical and water barrier properties of soy protein isolate based films. J Food Eng, 2009;91:509–15
  • Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol, 1996;20:64–74
  • Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60(4):110–11
  • Puebla P, Pastoriza P, Barcia E, Fernández-Carballido A. PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intraarticular administration. J Microencapsul, 2005;22(7):793–808
  • Rahman Z, Zidan AS, Habib MJ, Khan MA. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design. Int J Pharm, 2010;389(1–2):186–94
  • Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-Fickian release from nonswellable devices in the form of slabs, spheres, cylinders or discs. J Control Release, 1987a;5:23–36
  • Ritger PL, Peppas NA. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release, 1987b;5:37–42
  • Sinha VR, Trehan A. Development, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres as a depot system for parenteral delivery. Drug Delivery, 2008;15(6):365–72
  • Srinivasan C, Katare YK, Muthukumaran T, Panda AK. Effect of additives on the encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles. J Microencapsul, 2005;22:127–38
  • Tracy MA, Ward KL, Firouzabadian L, Wang Y, Dong N, Qian R, Zhang Y. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials, 1999;20:1057–63
  • Tzafriri AR. Mathematical modeling of diffusion-mediated release from bulk degrading matrices. J Control Release, 2000;63:69–79
  • Wagner JG, Nelson E. Percent absorbed time plots derived from blood level and/or urinary excretion data. J Pharm Sci, 1963;52:610–1
  • Wypych G. 2004. Handbook of plasticizers. Toronto, Canada: ChemTec and William Andrew Inc., pp. 147
  • Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials, 2001;22:231–41
  • Yang C, Plackett D, Needham D, Burt H. PLGA and PHBV microsphere formulations and solid-state characterization: Possible implications for local delivery of fusidic acid for the treatment and prevention orthopaedic infections. Pharm Res, 2009;26(7):1644–56
  • Zidan AS, Sammour OA, Hammad MA, Megrab NA, Hussain MD, Khan MA, Habib MJ. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers. AAPS PharmSciTech, 2006;7(3):Article 61: E1–E9
  • Zuccheri G, Asproulis N. 2012. Detection of pathogens in water using micro and nano-technology. London, UK: IWA Publishing

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.